News

Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
Federal health officials will allow Juul to keep selling its electronic cigarettes. The Food and Drug Administration said ...
FDA authorizes JUUL e-cigarettes for US market after delay
Fox News senior medical analyst Dr. Marc Siegel comments on JUUL use and a recent study on screen time and depression on ‘Fox ...
Juul gets FDA approval to keep selling e-cigarettes
FDA regulators said Thursday that Juul’s studies show its e-cigarettes are less harmful for adult smokers, who can benefit ...
FDA approves Juul's tobacco and menthol e-cigarettes
The U.S. Food and Drug Administration has authorized the sale of Juul Labs' e-cigarette device and refill cartridges in ...
FDA Authorizes Juul’s E-Cigarettes After Ban Nearly Bankrupted Firm
The regulator authorized the company to keep its e-cigarettes on the U.S. market after a federal ban in 2022 had pushed it to ...
Juul can continue to sell e-cigarettes, FDA says
Juul Labs can continue to sell its e-cigarettes and refill cartridges per a decision Thursday by the Food and Drug ...
FDA authorizes Juul e-cigarettes for use after fives years of deliberation, WSJ reports
The Food and Drug Administration has authorized Juul's original vaporizer and flavored cartridges to remain on the U.S.
ConsumerAffairs1d
FDA greenlights Juul’s e-cigarettes
FDA authorizes Juul’s tobacco- and menthol-flavored e-cigarettes to stay on U.S. shelves, reversing a previous ban due to new ...
Devdiscourse11h
FDA's Juicy Juul Decision: E-Cigarettes Approved Amidst Setbacks
The FDA has approved Juul Labs' tobacco and menthol e-cigarettes, marking a significant decision amidst regulatory challenges ...
CSP Daily News2d
FDA authorizes Juul e-cigarette device and menthol and tobacco pods
The Food and Drug Administration (FDA) has issued marketing granted orders (MGOs) for Juul e-cigarettes.
FDA reauthorizes Juul e-cigarettes following federal ban
In 2022, the FDA ordered Juul Labs to cease sales over toxicology questions, and that ban was later paused while the FDA was reviewing data.